Details
Stereochemistry | ACHIRAL |
Molecular Formula | C12H8O4 |
Molecular Weight | 216.1895 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C2C=CC(=O)OC2=C3C=COC3=C1
InChI
InChIKey=AJSPSRWWZBBIOR-UHFFFAOYSA-N
InChI=1S/C12H8O4/c1-14-9-6-10-8(4-5-15-10)12-7(9)2-3-11(13)16-12/h2-6H,1H3
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/23501157Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/6183897 | https://www.ncbi.nlm.nih.gov/pubmed/28556437 | https://www.ncbi.nlm.nih.gov/pubmed/6617185 | https://www.ncbi.nlm.nih.gov/pubmed/23649674
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23501157
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/6183897 | https://www.ncbi.nlm.nih.gov/pubmed/28556437 | https://www.ncbi.nlm.nih.gov/pubmed/6617185 | https://www.ncbi.nlm.nih.gov/pubmed/23649674
Isobergapten is a furanocoumarin found in Heracleum maximum and grapefruit and can block the liver enzyme cytochrome P450, having interactions with some medications. Isobergapten is the principal constituents responsible for the antimycobacterial activity of the roots of Heracleum maximum.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2366634 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23501157 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | Unknown Approved UseUnknown |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23501157
MIC andIC50 values were determined against Mycobacterium tuberculosis H37Ra using the MRA. Stock solutions(800 μg/mL) in sterile 4% DMSO in MGIT growth medium and used immediately. Serial two fold dilutions of test compound (Isobergapten) solutions (100 μL) were performed in 96-well microtitre assay plates with MGIT growth medium(100 μL) to give a series of 12 concentrations (400–0.20 μg/mL) in triplicate
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
482-48-4
Created by
admin on Fri Dec 15 19:45:21 GMT 2023 , Edited by admin on Fri Dec 15 19:45:21 GMT 2023
|
PRIMARY | |||
|
27X3V737WH
Created by
admin on Fri Dec 15 19:45:21 GMT 2023 , Edited by admin on Fri Dec 15 19:45:21 GMT 2023
|
PRIMARY | |||
|
68082
Created by
admin on Fri Dec 15 19:45:21 GMT 2023 , Edited by admin on Fri Dec 15 19:45:21 GMT 2023
|
PRIMARY | |||
|
DTXSID8075415
Created by
admin on Fri Dec 15 19:45:21 GMT 2023 , Edited by admin on Fri Dec 15 19:45:21 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD